One-Year Outcomes of the PAUL Glaucoma Implant Compared With the Ahmed Glaucoma Valve for the Treatment of Silicone Oil Glaucoma

被引:1
作者
Karapapak, Murat [1 ]
Olgun, Ali [2 ]
机构
[1] Univ Hlth Sci, Basaksehir Cam & Sakura City Hosp, Dept Ophthalmol, Basaksehir Olymp Blvd Rd, TR-34480 Istanbul, Turkiye
[2] West Eye Hosp, Dept Ophthalmol, Erbil, Iraq
关键词
Ahmed glaucoma valve; emulsified silicone oil; PAUL glaucoma implant; secondary glaucoma; PARS-PLANA VITRECTOMY; INTRAOCULAR-PRESSURE; DRAINAGE DEVICES; INJECTION; MANAGEMENT; COMPLICATIONS; SURGERY; EYES;
D O I
10.1097/IJG.0000000000002360
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Precis: Longer-term studies with a larger sample size are needed to demonstrate the superiority or equivalence of these procedures. Objective: To evaluate the outcomes of the PAUL glaucoma implant (PGI) and Ahmed glaucoma valve (AGV) in patients with secondary glaucoma caused due to silicone oil emulsification. Patients and Methods: A retrospective examination was conducted using the medical records of 36 patients who developed secondary glaucoma due to silicone oil emulsification after vitreoretinal surgery and then underwent PGI and AGV implantation surgery. The main outcome measures in the PGI and AGV groups were intraocular pressure (IOP) and its change, the number of antiglaucoma medications, and postoperative complications during the 12-month follow-up period. IOP of <6 mm Hg is used to define hypotonia. Results: There was no statistically significant difference among the patients who underwent PGI and AGV surgeries in terms of IOP averages, both preoperatively and postoperatively on day 1, week 1, month 1, month 3, month 6, and month 12 (P > 0.05). Before PGI and AGV implantation, the mean IOP was 40 +/- 13 mm Hg and 39.3 +/- 10 mm Hg, and the mean number of medications was 3.8 +/- 0.4 and 4 +/- 0, respectively. At the end of the 12-month follow-up period, the mean IOP was 13.5 +/- 2.2 (P < 0.001) mm Hg and 14.9 +/- 4.2 (P < 0.001) mm Hg, whereas the mean number of glaucoma medications decreased to 1.7 +/- 1.3 (P < 0.001) and 1.9 +/- 1.8 (P < 0.001) in the PGI and AGV groups, respectively. Surgical success was achieved in 17 of 18 eyes (94%) in the PGI group and 16 of 18 eyes (89%) in the AGV group. Conclusions: Although the outcomes were similar in both the PGI and AGV groups, complications requiring medical and surgical intervention were less common in the PGI group. Longer-term studies with a larger sample size are needed to demonstrate the superiority or equivalence of these procedures.
引用
收藏
页码:310 / 316
页数:7
相关论文
共 50 条
  • [41] Efficacy of intravitreal ranibizumab combined with Ahmed glaucoma valve implantation for the treatment of neovascular glaucoma
    Tang, Min
    Fu, Yang
    Wang, Ying
    Zheng, Zhi
    Fan, Ying
    Sun, Xiaodong
    Xu, Xun
    BMC OPHTHALMOLOGY, 2016, 16
  • [42] Intermediate outcomes of Ahmed glaucoma valve surgery in Asian patients with intractable glaucoma
    Tai, M-C
    Cheng, J-H
    Chen, J-T
    Liang, C-M
    Lu, D-W
    EYE, 2010, 24 (04) : 547 - 552
  • [43] Ahmed glaucoma valve implant: Experience in East Africa
    Kiage, D. O.
    Gradin, D.
    Gichuhi, S.
    Damji, K. F.
    MIDDLE EAST AFRICAN JOURNAL OF OPHTHALMOLOGY, 2009, 16 (03) : 151 - 155
  • [44] Long-term outcomes of the Ahmed glaucoma valve surgery in childhood glaucoma
    Mofti, Alaa
    Alharbi, Amjad
    Alsuhaibani, Marya
    Aljaber, Ahmed
    Altamimi, Lamees
    Ahmad, Sameer
    Al-Jadaan, Ibrahim
    Malik, Rizwan
    JOURNAL OF AAPOS, 2020, 24 (06): : 346.e1 - 346.e8
  • [45] Surgical Outcomes of Ahmed Glaucoma Valve and Aurolab Aqueous Drainage Implant in Nepalese Eyes: Comparison in the First Year
    Parajuli, Anil
    Paudyal, Indira
    Joshi, Pratibha Lama
    Thapa, Suman Shamsher
    NEPALESE JOURNAL OF OPHTHALMOLOGY, 2023, 15 (29) : 39 - 52
  • [46] Outcomes of Ahmed glaucoma valve FP8 versus FP7 in adult secondary glaucoma
    Ramyashri, S.
    Raj, Niranjan
    Pradhan, Amiya
    Ali, Mohammad Hasnat
    Rao, Aparna
    INTERNATIONAL OPHTHALMOLOGY, 2020, 40 (06) : 1359 - 1366
  • [47] A case involving an Ahmed(TM) glaucoma valve transferred from the vitreous into the anterior chamber of the eye with a silicone oil tamponade for the treatment of neovascular glaucoma
    Miki, Michiko
    Ueki, Mari
    Sugiyama, Tetsuya
    Kojima, Shota
    Ikeda, Tsunehiko
    CLINICAL OPHTHALMOLOGY, 2013, 7 : 449 - 453
  • [48] Long-term outcomes of uveitic glaucoma treated with Ahmed valve implant in a series of Chinese patients
    Bao, Ning
    Jiang, Zheng-Xuan
    Coh, Paul
    Tao, Li-Ming
    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2018, 11 (04) : 629 - 634
  • [49] Surgical outcomes of the Aurolab aqueous drainage implant (AADI) versus the Ahmed glaucoma valve for refractory paediatric glaucoma in Middle Eastern children
    Khan, Abdullah M.
    Ahmad, Khabir
    Alarfaj, Motazz
    Alotaibi, Humoud
    AlJaloud, Ahmad
    Malik, Rizwan
    BMJ OPEN OPHTHALMOLOGY, 2021, 6 (01):
  • [50] Ahmed glaucoma valve implant for refractory glaucoma in children: A systematic review and meta-analysis
    Fu, Xiangjun
    He, Juan
    Li, Guoliang
    Luo, Hongyi
    Peng, Ruijue
    Cheng, Yilian
    Peng, Jie
    Chen, Shiyan
    Qu, Chao
    SCIENCE PROGRESS, 2025, 108 (01)